longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

EXAS

EXAS
----

LongbridgeAI

OpenAI's CEO Altman: The company may seek partners or invest in AI drug discovery

Wallstreetcn
Feb 3, 2026 at 05:45 PM

OpenAI's CEO Altman: The company may seek partners or invest in AI drug discovery

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings

  • Apr 23, 2026 at 04:04 AMAfter Overnight Fame, 'OpenClaw' Faces a Choice
  • Apr 22, 2026 at 10:30 AMInnovative Drug Revenue Share Surpasses 60% for First Time, HENGRUI PHARMA Q1 Revenue Hits 8.14 Billion Yuan, Net Profit…
  • Apr 20, 2026 at 06:34 PMEli Lilly Announces $7 Billion Acquisition of Kelonia: Pioneering the 'In Vivo CAR-T' Frontier and Leading Gene Therapy …
  • Apr 13, 2026 at 01:07 AMU.S. Stocks Face a "Final Battle" as Hormuz Outcome Decides the Game: The Rash Never Win, the Patient Prevail

Related Stocks

Relay Therapeutics

Relay Therapeutics

USRLAY

-1.66%

Lantern Pharma

Lantern Pharma

USLTRN

WUXI APPTEC

WUXI APPTEC

HK02359